Trump drug price plan could nix investment, warns Roche / Photo: © AFP
-
BBVA, Sabadell clash heats up ahead of takeover deadline
-
World economy not doing as badly as feared, IMF chief says
-
Veggie 'burgers' face the chop as EU lawmakers back labeling ban
-
Former FBI chief James Comey pleads not guilty in case pushed by Trump
-
Germany raises growth forecasts, but warns reforms needed
-
Serie A chief blasts Rabiot's criticism of Milan match in Australia
-
From refugee to Nobel: Yaghi hails science's 'equalising force'
-
De Minaur, Auger-Aliassime through to Shanghai quarter-finals
-
Canal Istanbul stirs fear and uncertainty in nearby villages
-
Root backs England to end Ashes drought in Australia
-
British PM Starmer hails India opportunities after trade deal
-
England captain Kane could miss Wales friendly
-
Tennis increases support for players under corruption, doping investigation
-
Russia says momentum from Putin-Trump meeting 'gone'
-
EU wants key sectors to use made-in-Europe AI
-
De Minaur, Rinderknech through to Shanghai quarter-finals
-
Gisele Pelicot says 'never' gave consent to accused rapist
-
Thousands stranded as record floods submerge Vietnam streets
-
Sabalenka battles to keep Wuhan record alive, Pegula survives marathon
-
Trio wins chemistry Nobel for new form of molecular architecture
-
Tarnished image and cheating claims in Malaysia football scandal
-
Family affair as Rinderknech joins Vacherot in Shanghai quarters
-
New documentary shows life in Gaza for AFP journalists
-
Tennis stars suffer, wilt and quit in 'brutal' China heat
-
Wildlife flee as floods swamp Indian parks
-
Record flooding hits Vietnam city, eight killed in north
-
Battling cancer made Vendee Globe win 'more complicated', says skipper Dalin
-
England, Portugal, Norway closing in on 2026 World Cup
-
Child protection vs privacy: decision time for EU
-
Bear injures two in Japan supermarket, man killed in separate attack
-
In Simandou mountains, Guinea prepares to cash in on iron ore
-
Morikawa says not to blame for 'rude' Ryder Cup fans
-
Far right harvests votes as climate rules roil rural Spain
-
'Return to elegance': highlights from Paris Fashion Week
-
Britain's storied Conservative party faces uncertain future
-
New Zealand's seas warming faster than global average: report
-
Snakebite surge as Bangladesh hit by record rains
-
Yankees deny Blue Jays playoff sweep as Mariners beat Tigers
-
Australia police foil 'kill team' gang hit near daycare centre
-
US, Qatar, Turkey to join third day of Gaza peace talks in Egypt
-
Gold tops $4,000 for first time as traders pile into safe haven
-
Indian garment exporters reel under US tariffs
-
NBA back in China after six-year absence sparked by democracy tweet
-
Energy storage and new materials eyed for chemistry Nobel
-
Trump unlikely to win Nobel Peace Prize, but who will?
-
Qatar, Turkey to join third day of Gaza peace talks in Egypt
-
Study finds women have higher genetic risk of depression
-
Dolly Parton's sister calls for fan prayers over health issues
-
On Trump's orders, 200 troops from Texas arrive in Illinois
-
Two bodies found, two missing after Madrid building collapse
NYSE - LSE
| RBGPF | -1.4% | 77.14 | $ | |
| CMSC | 0.05% | 23.75 | $ | |
| BTI | -0.88% | 51.525 | $ | |
| NGG | -0.18% | 73.75 | $ | |
| BP | -0.34% | 34.853 | $ | |
| RIO | 2.3% | 67.81 | $ | |
| GSK | 0.41% | 43.68 | $ | |
| SCS | 0.24% | 16.9 | $ | |
| RELX | 0.83% | 45.82 | $ | |
| AZN | -0.02% | 85.85 | $ | |
| BCC | 1.46% | 75.625 | $ | |
| JRI | 0.57% | 14.15 | $ | |
| CMSD | -0.29% | 24.33 | $ | |
| BCE | -0.06% | 23.275 | $ | |
| VOD | 0.44% | 11.32 | $ | |
| RYCEF | -1.24% | 15.35 | $ |
Trump drug price plan could nix investment, warns Roche
President Donald Trump's plans to dramatically slash drug prices for Americans could make Swiss pharmaceutical giant Roche cancel major investments in the United States, it said Wednesday.
Trump signed an executive order Monday aimed at bringing down the notoriously high prescription drug prices paid by US consumers, news that rattled pharmaceutical companies.
Swiss newspaper NZZ reported Trump's move could lead Roche to reassess plans it announced just last month to invest $50 billion in the United States over five years.
Roche, the world leader in cancer treatments, said in a statement it did not expect Trump's new drugs policy to hurt its business in 2025.
"However, should the proposed EO (executive order) go into effect, Roche's ability to fund the significant investments previously announced in the US will be in question," it said.
Trump has been pushing foreign firms to invest more in the United States, saying the way to avoid his tariff assault on foreign-made goods is to produce them on US soil instead.
Prescription drugs were not targeted in Trump's "Liberation Day" tariff announcements.
Still, Roche appeared to take heed with its April investment announcement, which came just after fellow Swiss rival Novartis said it would increase investment in the United States by $23 billion over five years.
The United States is a key market for Roche, accounting for more than half its pharmaceutical division's revenues.
Roche's US subsidiary Genentech announced a $700-million project Monday to build a new plant in North Carolina, which it says would employ 400 people.
F.Fehr--VB
